Modified Guarnieri-Desarda Technique Versus Lichtenstein Technique in Inguinal Hernia Repair

March 12, 2025 updated by: Fadi Fawzi Azmi Khalil, Cairo University

Comparative Study of Modified Guarnieri-Desarda Technique Versus Lichtenstein Technique in Inguinal Hernia Repair

The aim of this study is to compare the surgical outcome of both Lichnichtien tension free mesh hernioplasty of inguinal hernia and the combined modified Guarnieri Desarda technique in terms of postoperative pain, post operative complications (seroma, hematoma, wound infection), chronic inguinodenia, early recurrence and assessment of testicular vascularity and size by application of a testicular duplex and ultrasound.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Adult male patients aged 18 years or older.
  • Patients diagnosed with non-complicated inguinal hernia (both direct and indirect).
  • Patients able to provide written informed consent to participate in the study.

Exclusion Criteria:

  • Patients younger than 18 years old.
  • Patients with complicated hernias (e.g., inflamed, obstructed, or strangulated hernias).
  • Patients with a recurrent inguinal hernia.
  • Patients with weak or thin external oblique aponeurosis (intraoperative findings).
  • Patients with a history of prior surgery in the inguinal region.
  • Patients who refuse to participate in the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Lichtenstein Mesh-Based Repair
Participants in this arm will undergo the Lichtenstein tension-free hernioplasty, which involves reinforcing the inguinal canal floor using a synthetic mesh. The mesh is fixed to the inguinal ligament and internal oblique aponeurosis, minimizing tension in the repair and reducing the risk of recurrence.
This is a tension-free hernioplasty procedure that uses a synthetic mesh to reinforce the inguinal canal floor. The mesh is fixed to the inguinal ligament and internal oblique aponeurosis, creating a barrier to prevent hernia recurrence. It is considered the gold standard for inguinal hernia repair and is widely used for its effectiveness in reducing recurrence rates and postoperative complications.
Experimental: Combined Modified Guarnieri-Desarda Tissue-Based Repair
Participants in this arm will receive the combined modified Guarnieri-Desarda tissue-based repair. This approach involves reconstructing the inguinal canal without the use of synthetic mesh, using the patient's own tissues to reinforce the canal and reduce tension. The technique combines aspects of both the Guarnieri and Desarda methods, aiming to preserve the natural physiology of the inguinal canal while providing tension-free repair.
This technique combines elements of the Guarnieri and Desarda tissue-based repairs. It does not involve the use of synthetic mesh, relying instead on the patient's own tissues to reinforce the inguinal canal. The Guarnieri technique reshapes the internal ring to improve the inguinal canal's shutter mechanism, while the Desarda technique reinforces the posterior wall using the external oblique aponeurosis. This approach aims to preserve natural anatomy and minimize complications associated with mesh use.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Postoperative Pain Assessment
Time Frame: At 2 weeks, 1 month, 3 months, and 6 months post-surgery.
Postoperative pain will be evaluated using the Mankoski Pain Scale (0-10). Pain scores will be recorded at different time intervals to assess immediate and long-term postoperative pain, with scores from 0 to 2 considered negligible, and scores from 3 to 10 considered significant.
At 2 weeks, 1 month, 3 months, and 6 months post-surgery.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Incidence of Postoperative Complications
Time Frame: At 2 weeks, 1 month, and 3 months post-surgery.
The occurrence of postoperative complications such as seroma, hematoma, wound infection, and testicular complications (e.g., hydrocele, cord induration) will be recorded and analyzed for each group.
At 2 weeks, 1 month, and 3 months post-surgery.
Hernia Recurrence Rate
Time Frame: At 6 months and 1 year post-surgery.
The rate of hernia recurrence will be assessed through clinical examination and imaging, comparing recurrence between the Lichtenstein mesh-based repair group and the modified Guarnieri-Desarda tissue-based repair group.
At 6 months and 1 year post-surgery.
Testicular Vascularity
Time Frame: At 3 months post-surgery.
Testicular vascularity will be evaluated using testicular duplex and ultrasound, comparing any changes pre- and post-surgery between the two groups.
At 3 months post-surgery.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Fadi F. Khalil, MSc, Kasr El Aini Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 10, 2024

Primary Completion (Estimated)

October 1, 2025

Study Completion (Estimated)

October 1, 2025

Study Registration Dates

First Submitted

September 10, 2024

First Submitted That Met QC Criteria

September 12, 2024

First Posted (Actual)

September 19, 2024

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

March 12, 2025

Last Verified

March 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

De-identified individual participant data (IPD) including demographic information, surgical outcomes, and follow-up data (postoperative pain scores, complications, testicular vascularity and size, and hernia recurrence rates) will be made available. Data will be shared with researchers upon reasonable request for the purpose of secondary analysis. Access to the data will be granted following the publication of the study results and will be available for up to 5 years after study completion. Participants' confidentiality will be protected, and any shared data will be anonymized.

IPD Sharing Time Frame

Data will be available for a period of 5 years after the study is completed.

IPD Sharing Access Criteria

Who: Qualified researchers with a scientifically sound proposal will be able to access the individual participant data (IPD) and supporting information.

What: Researchers will be able to access de-identified IPD, including demographic data, surgical outcomes, follow-up data (e.g., pain scores, complications, testicular vascularity, and hernia recurrence), and supporting documents such as the study protocol, statistical analysis plan, and informed consent form.

How: Researchers must submit a formal request to the corresponding author detailing their research proposal, the objectives of the secondary analysis, and how the data will be used. Requests will be evaluated by the study investigators. If approved, data will be shared via a secure, password-protected data-sharing platform, ensuring compliance with data protection regulations.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • ICF

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Inguinal Hernia

Clinical Trials on Lichtenstein Mesh-Based Hernioplasty

Subscribe